HuagongsheHuagongshe Chemistry Print Report · For research reference only
3-(1-Piperazinyl)-1,2-benzisothiazole monohydrochloride → 3-{4-[2-(3-Methyl-2-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 3-(1-Piperazinyl)-1,2-benzisothiazole monohydrochloride | HCID 11521711 | — |
| Reactant | 3-Methyl-2-nitrophenethyl tosylate | HCID 21963219 | — |
| Product | 3-{4-[2-(3-Methyl-2-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole | HCID 21963177 | 11% |
Reaction Steps
3-{4-[2-(3-Methyl-2-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole was prepared according to the general method as outlined in Preparation 2 starting with 3-piperazin-1-yl-benzoisothiazole hydrochloride (1.71 g, 6.7 mmol) and 3-methyl-2-nitrophenethyl tosylate (1.8 g, 5.37 mmol). The product was isolated via column chromatography to afford 290 mg of brown oil. Yield 11%; MS (APCI): 383 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07101886B2 |
| Source dataset | uspto-grants-2006_09 |
| ORD ID | ord-c21bd87ad10747dfae2ebcab5eebd712 |
| Source note | uspto-grants-2006_09 |